期刊文献+

奥曲肽对系统性红斑狼疮患者体外培养单一核细胞增殖及分泌细胞因子的影响 被引量:4

Effect of octreotide on the secretion of cytokines by and proliferation of cultured PBMCs from patients with systemic lupus erythematosus
原文传递
导出
摘要 目的探讨奥曲肽对SLE患者体外培养单一核细胞增殖及其分泌细胞因子的影响。方法对SLE患者和正常人对照的单一核细胞进行体外培养,用MTT法测定单一核细胞加入不同浓度奥曲肽后的细胞增殖率,计算不同浓度奥曲肽对单一核细胞的抑制率,同时以生长激素加奥曲肽进行干预,并测定细胞因子的分泌水平。结果0.1 ng/mL奥曲肽对单一核细胞增殖无抑制作用,1 ng/mL奥曲肽开始有微弱的抑制作用,10 ng/mL奥曲肽有明显的抑制作用,且呈剂量依赖性。SLE患者外周血单一核细胞在体外经奥曲肽干预后,其IL-6、IL-10和IFN-γ分泌量较未处理组显著下降,生长激素加奥曲肽共同干预后的分泌量较生长激素干预的分泌量显著下降。结论奥曲肽体外能抑制单一核细胞增殖,且能抑制生长激素诱导的细胞因子的分泌。 Objective To investigate the effect of octreotide ( OCT ) on the proliferation capacity of and secretion of cytokines by cultured PBMCs from patients with systemic lupus erythematosus ( SLE ). Methods PBMCs from patients with SLE and healthy controls were cultured in vitro with various concentrations of OCT, pretreated with or without growth hormone ( GH ). The proliferation capacity of PBMCs was detected by MTT method, and the secretion of cytokines by PBMCs was measured with ELISA. Restilts OCT could inhibit the proliferation capacity of PBMCs in a dose dependent manner: 0.1 ng/mL of OCT had no effect on the proliferation, 1 ng/mL OCT had a weak inhibitory effect, and 10 ng/mL OCT had a marked inhibitory effect. The secretion of IL-6, IL-10 and IFN-γ by PBMCs was significantly decreased with the treatment of OCT, and was also significantly decreased with the co-treatment of GH and OCT compared to that with the treatment of GH only. Conclusion OCT can inhibit the proliferation capacity of PBMCs and secreation of IL-6, IL-10 and IFN-γ by PBMCs induced by GH.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2006年第9期527-529,共3页 Chinese Journal of Dermatology
基金 国家自然科学基金(39970688)
关键词 红斑狼疮 系统性 奥曲肽 生长激素 白细胞介素6 白细胞介素10 干扰素Ⅱ型 Lupus erythematosus, systemic Octreotide Growth hormone Interleukin-6 Inter-leukin- 10 Interferon type Ⅱ
  • 相关文献

参考文献8

二级参考文献11

  • 1黄勤 张家庆.白介素等细胞因子对人眼球后和皮肤成纤维细胞的作用[J].中国免疫学,1996,12:69-72.
  • 2黄勤,中国免疫学杂志,1996年,12卷,69页
  • 3Chang T C,Br Med J,1992年,304卷,158页
  • 4Murphy W J,Life Sci,1995年,57卷,1页
  • 5Elliott DE, Li J, Blum AM, et al. SSTR2A is the dominant soma-tostatin receptor subtype expressed by inflammatory cells, is widely expressed and directly regulates T cell IFN-gamma release. Eur J Immunol, 1999, 29: 2454-2463.
  • 6Levite M. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci U S A, 1998, 95: 12544-12549.
  • 7Grondal G,Kristjansdottir H,Gunnlaugsdottir B,et al.Increased number of interleukin—10—producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic muhicase families.Arthritis Rheum,1999,42:1649—1654.
  • 8Llorente L,Richaud—Patin Y,Garcia—Padilla C,et a1.Clinical and biologic effects of anti—interleukin-10 monoclonal antibody administration in systemic lupus erythematosus.Arthritis Rheum,2000,43:1790-1800.
  • 9Viallard JF,Pellegrin JL,Ranchin V,et al.Th l(IL-2),interferon—gamma(IFN—gamma)and Th2(IL-10,IL-4)cytokine production by peripheral blood mononuclear cells(PBMC)from patients with systemic lupus erythematosus(SLE).Clin Exp Immunol,1999,1 15:189-195.
  • 10李峰,冯树芳,徐金华,黄岚,邓守贞.系统性红斑狼疮患者血清生长激素和泌乳素动态变化的研究[J].中华皮肤科杂志,2000,33(4):261-263. 被引量:12

共引文献19

同被引文献74

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部